HUBASE Trademark

Trademark Overview

On Wednesday, February 2, 2011, a trademark application was filed for HUBASE with the United States Patent and Trademark Office. The USPTO has given the HUBASE trademark a serial number of 85232455. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, December 17, 2022. This trademark is owned by Crown Bioscience Inc.. The HUBASE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting preclinical drug studies, and provide predictive modeling platforms and expertise to translate those results into insightful clinical design strategies for successful clinical trial outcomes; Conducting research and preclinical trials relating to pharmaceuticals in the field of translational oncology and drug development; providing an on-line searchable database featuring medical research information and predictive modeling platforms in the field of oncology for providing users with insightful clinical trial design strategies for successful clinical trial outcomes
hubase

General Information

Serial Number85232455
Word MarkHUBASE
Filing DateWednesday, February 2, 2011
Status800 - REGISTERED AND RENEWED
Status DateSaturday, December 17, 2022
Registration Number4152629
Registration DateTuesday, June 5, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 20, 2012

Trademark Statements

Pseudo MarkHU BASE ; HUMAN BASE
Goods and ServicesMedical and scientific research, namely, conducting preclinical drug studies, and provide predictive modeling platforms and expertise to translate those results into insightful clinical design strategies for successful clinical trial outcomes; Conducting research and preclinical trials relating to pharmaceuticals in the field of translational oncology and drug development; providing an on-line searchable database featuring medical research information and predictive modeling platforms in the field of oncology for providing users with insightful clinical trial design strategies for successful clinical trial outcomes

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 7, 2011
Primary Code042
First Use Anywhere DateFriday, January 1, 2010
First Use In Commerce DateMonday, February 1, 2010

Trademark Owner History

Party NameCrown Bioscience Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92127
Party NameCrown Bioscience Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95054
Party NameCrown Bioscience Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95054

Trademark Events

Event DateEvent Description
Saturday, December 17, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, December 17, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, December 17, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, December 17, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 2, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, June 5, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, April 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 2, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, June 1, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, May 31, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 18, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, June 5, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 5, 2012REGISTERED-PRINCIPAL REGISTER
Monday, May 7, 2012ASSIGNED TO EXAMINER
Tuesday, March 20, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 20, 2012PUBLISHED FOR OPPOSITION
Wednesday, February 29, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 15, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 14, 2012ASSIGNED TO LIE
Monday, January 30, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 10, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 9, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 9, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 9, 2012PETITION TO REVIVE-GRANTED
Monday, January 9, 2012TEAS PETITION TO REVIVE RECEIVED
Monday, December 5, 2011ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, December 5, 2011ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, May 9, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 9, 2011NON-FINAL ACTION E-MAILED
Monday, May 9, 2011NON-FINAL ACTION WRITTEN
Monday, May 2, 2011ASSIGNED TO EXAMINER
Tuesday, February 8, 2011NOTICE OF PSEUDO MARK MAILED
Monday, February 7, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 5, 2011NEW APPLICATION ENTERED

Related Keywords

hubase clinical trial research successful strategies medical outcomes providing oncology field